These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 12198334)

  • 1. N(G)-nitro-L-arginine methyl ester-induced hypertension and natriuretic peptide gene expression: inhibition by angiotensin II type 1 receptor antagonism.
    Suo M; Kalliovalkama J; Pörsti I; Jolma P; Tolvanen JP; Vuolteenaho O; Ruskoaho H
    J Cardiovasc Pharmacol; 2002 Sep; 40(3):478-86. PubMed ID: 12198334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential regulation of cardiac adrenomedullin and natriuretic peptide gene expression by AT1 receptor antagonism and ACE inhibition in normotensive and hypertensive rats.
    Magga J; Kalliovalkama J; Romppanen H; Vuolteenaho O; Pörsti I; Kähönen M; Tolvanen JP; Ruskoaho H
    J Hypertens; 1999 Nov; 17(11):1543-52. PubMed ID: 10608466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arterial function in nitric oxide-deficient hypertension: influence of long-term angiotensin II receptor antagonism.
    Kalliovalkama J; Jolma P; Tolvanen JP; Kähönen M; Hutri-Kähönen N; Wu X; Holm P; Pörsti I
    Cardiovasc Res; 1999 Jun; 42(3):773-82. PubMed ID: 10533618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of nitric oxide on cardiac hormone secretion: effect of NG-nitro-L-arginine methyl ester on atrial natriuretic peptide and brain natriuretic peptide release.
    Leskinen H; Vuolteenaho O; Leppäluoto J; Ruskoaho H
    Endocrinology; 1995 Mar; 136(3):1241-9. PubMed ID: 7867578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II type 1 receptor antagonism improves endothelial vasodilator function in L-NAME-induced hypertensive rats by a kinin-dependent mechanism.
    De Gennaro Colonna V; Fioretti S; Rigamonti A; Bonomo S; Manfredi B; Muller EE; Berti F; Rossoni G
    J Hypertens; 2006 Jan; 24(1):95-102. PubMed ID: 16331106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discoordinate re-expression of cardiac fetal genes in N(omega)-nitro-L-arginine methyl ester (L-NAME) hypertension.
    Zhang Y; Carreras D; de Bold AJ
    Cardiovasc Res; 2003 Jan; 57(1):158-67. PubMed ID: 12504825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
    Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II subtype AT1 receptor blockade prevents hypertension and renal insufficiency induced by chronic NO-synthase inhibition in rats.
    Hropot M; Langer KH; Wiemer G; Grötsch H; Linz W
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Mar; 367(3):312-7. PubMed ID: 12644905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of NO and angiotensin II in the early development of endothelial functions impairment and cardiac hypertrophy in deoxycorticosterone acetate-salt hypertension.
    K-Laflamme A; Oster L; Cardinal R; de Champlain J
    Can J Physiol Pharmacol; 1998 Jun; 76(6):665-75. PubMed ID: 9923405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic morphological alterations, glycogen content and cytochrome P450 activities in rats treated chronically with N(omega)-nitro-L-arginine methyl ester (L-NAME).
    Tarsitano CA; Paffaro VA; Pauli JR; da Silva GH; Saad MJ; Salgado I; da Cruz-Höfling MA; Hyslop S
    Cell Tissue Res; 2007 Jul; 329(1):45-58. PubMed ID: 17436021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sympathetic functions in NG-nitro-L-arginine-methyl-ester-induced hypertension: modulation by the renin-angiotensin system.
    K-Laflamme A; Foucart S; Moreau P; Lambert C; Cardinal R; de Champlain J
    J Hypertens; 1998 Jan; 16(1):63-76. PubMed ID: 9533419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential subcellular actions of ACE inhibitors and AT(1) receptor antagonists on cardiac remodeling induced by chronic inhibition of NO synthesis in rats.
    Sanada S; Kitakaze M; Node K; Takashima S; Ogai A; Asanuma H; Sakata Y; Asakura M; Ogita H; Liao Y; Fukushima T; Yamada J; Minamino T; Kuzuya T; Hori M
    Hypertension; 2001 Sep; 38(3):404-11. PubMed ID: 11566913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition.
    Okazaki H; Minamino T; Tsukamoto O; Kim J; Okada K; Myoishi M; Wakeno M; Takashima S; Mochizuki N; Kitakaze M
    Hypertens Res; 2006 Apr; 29(4):277-84. PubMed ID: 16778335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostacyclin and thromboxane A2 production in nitric oxide-deficient hypertension in vivo. Effects of high calcium diet and angiotensin receptor blockade.
    Alanko J; Jolma P; Kööbi P; Riutta A; Kalliovalkama J; Tolvanen JP; Pörsti I
    Prostaglandins Leukot Essent Fatty Acids; 2003 Nov; 69(5):345-50. PubMed ID: 14580369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Angiotensin II type 1 receptor on renal NAD(P)H oxidase, oxidative stress and inflammation in nitric oxide inhibition induced-hypertension.
    Rincón J; Correia D; Arcaya JL; Finol E; Fernández A; Pérez M; Yaguas K; Talavera E; Chávez M; Summer R; Romero F
    Life Sci; 2015 Mar; 124():81-90. PubMed ID: 25623850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal and vascular effects of chronic nitric oxide synthase inhibition: involvement of endothelin 1 and angiotensin II.
    D'Amours M; Lebel M; Grose JH; Larivière R
    Can J Physiol Pharmacol; 1999 Jan; 77(1):8-16. PubMed ID: 10535660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of bradykinin on cardiovascular remodeling in renovascular hypertensive rats.
    Tanaka Y; Nagai M; Date T; Okada T; Abe Y; Seki S; Taniguchi M; Taniguchi I; Mochizuki S
    Hypertens Res; 2004 Nov; 27(11):865-75. PubMed ID: 15824469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II activates collagen type I gene in the renal vasculature of transgenic mice during inhibition of nitric oxide synthesis: evidence for an endothelin-mediated mechanism.
    Boffa JJ; Tharaux PL; Placier S; Ardaillou R; Dussaule JC; Chatziantoniou C
    Circulation; 1999 Nov; 100(18):1901-8. PubMed ID: 10545435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of effect of endothelin antagonism and angiotensin-converting enzyme inhibition on blood pressure and vascular structure in spontaneously hypertensive rats treated with N omega-nitro-L-arginine methyl ester. Correlation with topography of vascular endothelin-1 gene expression.
    Li JS; Deng LY; Grove K; Deschepper CF; Schiffrin EL
    Hypertension; 1996 Aug; 28(2):188-95. PubMed ID: 8707380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Contribution of the renin-angiotensin system to the variability of blood pressure in hypertensive rat after blockade of nitric oxide synthesis].
    Gouédard O; Gaudet E; Blanc J; Ponchon P; Elghozi JL
    Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1013-7. PubMed ID: 8949370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.